PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Large-scale identification and analysis of suppressive drug interactions

2014-04-24
(Press-News.org) TORONTO – Baker's yeast is giving scientists a better understanding of drug interactions, which are a major cause of hospitalization and illness world-wide.

When two or more medications are taken at the same time, one can suppress or enhance the effectiveness of the other. Similarly, one drug may magnify the toxicity of another. These types of interactions are a major cause of illness and hospitalization. However, there are severe practical limits on the practical scope of drug studies in humans. Limits come in part from ethics and in part from the staggering expense. Because of the vast number of combinations of different drugs that might be prescribed together in the same patient, drug interactions in patients are not extensively studied, even in the process of reviewing new drugs for approval.

This limitation has caused researchers to turn to simpler model organisms in which to study drug interactions, enabling systematic study of drug interactions at relatively low cost, according toresearchers at the Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital in Toronto. Dr. Frederick Roth and international colleagues published their findings after testing drugs on the simple yeast Saccharomyces cerevisiae, also known as brewer's yeast or baker's yeast.

Surprising effect

"Baker's yeast is a wonderful tool for this purpose," says Dr. Roth. "Many aspects of both yeast and human genomes have remained the same since they diverged from a common ancestor around one billion years ago. When a specific combination of drugs has a surprising effect on yeast growth there is no guarantee that it will do the same thing tohuman cells. But it does give us a general idea of how often drugs are able to enhance or suppress each other's effectiveness." Dr. Roth is a Senior Investigator at the Lunenfeld-Tanenbaum and a Professor at the University of Toronto's Donnelly Centre. He also holds a Canada Excellence Research Chair in Integrative Biology.

For this first test, the team worked with anti-fungal chemicals in a total of 440 drug pairs. They found that, in almost one fifth of the combinations, one drug reduced the effectiveness of the other drug. They also found that some drugs can have a greater tendency to suppress other drugs, while other drugs are more frequently suppressed. The same team published a related study in 2011, showing that for about one third of drug pairs tested the compounds increased each other's effectiveness. "If drug interactions are happening at anything approaching these rates in humans, we should be very concerned," Dr. Roth adds.

When one drug suppresses the effectiveness of another drug, "the patient is losing benefit from one or both drugs, while still potentially being exposed to their side effects," Dr. Roth adds. When a drug combination has an effect that is more than the sum of its parts, the patient might get too much of a good thing, and it is possible for drugs to intensify each other's toxicity as well.

"This methodology may also prove useful to explore positive types of drug interactions such as in personalized medicine," adds Dr. Jim Woodgett, Director of the Lunenfeld-Tanenbaum. "Diseases such as cancer rarely respond to single medications, and this new systematic technological approach may have the potential to allow rapid optimization of combination therapies," he notes. The study noted one example of a compound (Staurosporine) that was suppressed by acidity. This phenomenon is interesting in the context of cancer because the peculiar metabolism of cancer cells often makes the local tumour environment more acidic. It would be particularly exciting to find more anti-cancer compounds that were enhanced by acidity.

INFORMATION:

The paper "Large-scale identification and analysis of suppressive drug interactions" is published in Chemistry & Biology (Cell Press), April 24, 2014. An editorial published in the same issue supports continued development of this research approach. Coauthors include researchers from Cold Spring Harbor Laboratory, Dana-Farber Cancer Institute, UC San Francisco, Sabanci University (Istanbul), University of Toronto, and Boehringer Ingleheim Pharmaceuticals.

Drug Interactions - Backgrounder Adverse drug reactions (including interactions) have significant impact on visits to ED, hospitalization, health outcomes, and cost* Most of our knowledge of drug interactions relies on reporting by individual patients and physicians Drug classes that can interact negatively with other medications include: antibiotics, blood thinners, diuretics, hypoglycemics, chemotherapy, NSAIDs Individuals at risk of drug interactions include those who: Take a medication long-term (e.g., for birth control, hypertension), who may then take other medications Are elderly, infants, or children Have a complex medical condition for which several drugs (including over-the-counter) are used, either at home or in hospital

*e.g., Pirmohamed M. et al., Adverse drug reactions as a cause of admission to hospital: prospective analysis of 18,820 patients, BMJ 2004;329:15 .

For information or interview with Dr. Roth:
Polly Thompson
Lunenfeld-Tanenbaum Research Institute
Mount Sinai Hospital
Toronto, Canada
(416) 586-4800 #2046
pthompson@lunenfeld.ca


ELSE PRESS RELEASES FROM THIS DATE:

Skin layer grown from human stem cells could replace animals in drug and cosmetics testing

2014-04-24
An international team led by King's College London and the San Francisco Veteran Affairs Medical Center (SFVAMC) has developed the first lab-grown epidermis – the outermost skin layer - with a functional permeability barrier akin to real skin. The new epidermis, grown from human pluripotent stem cells, offers a cost-effective alternative lab model for testing drugs and cosmetics, and could also help to develop new therapies for rare and common skin disorders. The epidermis, the outermost layer of human skin, forms a protective interface between the body and its external ...

Scripps Research Institute scientists find new point of attack on HIV for vaccine development

Scripps Research Institute scientists find new point of attack on HIV for vaccine development
2014-04-24
LA JOLLA, CA— April 24, 2014 —A team led by scientists at The Scripps Research Institute (TSRI) working with the International AIDS Vaccine Initiative (IAVI) has discovered a new vulnerable site on the HIV virus. The newly identified site can be attacked by human antibodies in a way that neutralizes the infectivity of a wide variety of HIV strains. "HIV has very few known sites of vulnerability, but in this work we've described a new one, and we expect it will be useful in developing a vaccine," said Dennis R. Burton, professor in TSRI's Department of Immunology and Microbial ...

Three-banded panther worm debuts as a new model in the study of regeneration

Three-banded panther worm debuts as a new model in the study of regeneration
2014-04-24
CAMBRIDGE, Mass. (April 24, 2014) – Closely resembling plump grains of wild rice set in motion, the three-banded panther worms swimming in disposable containers in Whitehead Institute Member Peter Reddien's lab hardly seem like the next big thing in regeneration. And yet, these little-studied organisms possess the ability to regenerate any part of their bodies and are amenable to molecular studies in the lab, making them a valuable addition to a field keen on understanding how mechanisms controlling regeneration have evolved over millennia and how they might be activated ...

Engineered E. coli produces high levels of D-ribose as described in Industrial Biotechnology journal

Engineered E. coli produces high levels of D-ribose as described in Industrial Biotechnology journal
2014-04-24
New Rochelle, NY, April 24, 2014—D-ribose is a commercially important sugar used as a sweetener, a nutritional supplement, and as a starting compound for synthesizing riboflavin and several antiviral drugs. Genetic engineering of Escherichia coli to increase the bacteria's ability to produce D-ribose is a critical step toward achieving more efficient industrial-scale production of this valuable chemical, as described in an article in Industrial Biotechnology, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available on the Industrial Biotechnology ...

Oxygen diminishes the heart's ability to regenerate, researchers discover

Oxygen diminishes the hearts ability to regenerate, researchers discover
2014-04-24
DALLAS – April 24, 2014 – Scientific research at UT Southwestern Medical Center previously discovered that the newborn animal heart can heal itself completely, whereas the adult heart lacks this ability. New research by the same team today has revealed why the heart loses its incredible regenerative capability in adulthood, and the answer is quite simple – oxygen. Yes, oxygen. It is well-known that a major function of the heart is to circulate oxygen-rich blood throughout the body. But at the same time, oxygen is a highly reactive, nonmetallic element and oxidizing agent ...

New study helps to explain why breast cancer often spreads to the lung

2014-04-24
New research led by Alison Allan, PhD, a scientist at Western University and the Lawson Health Research Institute, shows why breast cancer often spreads or metastasizes to the lung. Breast cancer is the number one diagnosed cancer and the number two cause of cancer-related deaths among women in North America. If detected early, traditional chemotherapy and radiation have a high success rate, but once the disease spreads beyond the breast, many conventional treatments fail. In particular, the lung is one of the most common and deadly sites of breast cancer metastasis ...

Parents of severely ill children see benefits as caregivers, says study

2014-04-24
Benefits often coexist with the negative and stressful outcomes for parents who have a child born with or later diagnosed with a life-limiting illness, says a recent study led by a researcher at the University of Waterloo. While the challenges are numerous and life-changing and stress levels high, the vast majority of parents who participated in the Waterloo-led research reported positive outcomes as well, a phenomenon known as posttraumatic growth. The findings appear in the most recent issue of the American Journal of Orthopsychiatry. "What is pivotal is the meaning ...

'Double-duty' electrolyte enables new chemistry for longer-lived batteries

Double-duty electrolyte enables new chemistry for longer-lived batteries
2014-04-24
OAK RIDGE, Tenn., April 24, 2014 — Researchers at the Department of Energy's Oak Ridge National Laboratory have developed a new and unconventional battery chemistry aimed at producing batteries that last longer than previously thought possible. In a study published in the Journal of the American Chemical Society, ORNL researchers challenged a long-held assumption that a battery's three main components -- the positive cathode, negative anode and ion-conducting electrolyte -- can play only one role in the device. The electrolyte in the team's new battery design has ...

Cell resiliency surprises scientists

Cell resiliency surprises scientists
2014-04-24
EAST LANSING, Mich. --- New research shows that cells are more resilient in taking care of their DNA than scientists originally thought. Even when missing critical components, cells can adapt and make copies of their DNA in an alternative way. In a study published in this week's Cell Reports, a team of researchers at Michigan State University showed that cells can grow normally without a crucial component needed to duplicate their DNA. "Our genetic information is stored in DNA, which has to be continuously monitored for damage and copied for growth," said Kefei Yu, ...

Vanderbilt study finds physical signs of depression common among ICU survivors

Vanderbilt study finds physical signs of depression common among ICU survivors
2014-04-24
Depression affects more than one out of three survivors of critical illness, according to a Vanderbilt study released in The Lancet Respiratory Medicine, and the majority of patients experience their symptoms physically rather than mentally. It is one of the largest studies to investigate the mental health and functional outcomes of critical care survivors, according to lead author James Jackson, Psy.D., assistant professor of Medicine, and it highlights a significant public health issue, with roughly 5 million patients admitted to intensive care units (ICUs) in the United ...

LAST 30 PRESS RELEASES:

Osteoporosis treatment benefits people older than 80

Consuming more protein may protect patients taking anti-obesity drug from muscle loss

Thyroid treatment may improve gut health in people with hypothyroidism

Combination of obesity medication tirzepatide and menopause hormone therapy fuels weight loss

High blood sugar may have a negative impact on men’s sexual health

Emotional health of parents tied to well-being of children with growth hormone deficiency

Oxytocin may reduce mood changes in women with disrupted sleep

Mouse study finds tirzepatide slowed obesity-associated breast cancer growth

CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury

Melatonin receptor 1a alleviates sleep fragmentation-aggravated testicular injury in T2DM by suppression of TAB1/TAK1 complex through FGFR1

Single-cell RNA sequencing reveals Shen-Bai-Jie-Du decoction retards colorectal tumorigenesis by regulating the TMEM131–TNF signaling pathway-mediated differentiation of immunosuppressive dendritic ce

Acta Pharmaceutica Sinica B Volume 15, Issue 7 Publishes

New research expands laser technology

Targeted radiation offers promise in patients with metastasized small cell lung cancer to the brain

A high clinically translatable strategy to anti-aging using hyaluronic acid and silk fibroin co-crosslinked hydrogels as dermal regenerative fillers

Mount Sinai researchers uncover differences in how males and females change their mind when reflecting on past mistakes

CTE and normal aging are difficult to distinguish, new study finds

Molecular arms race: How the genome defends itself against internal enemies

Tiny chip speeds up antibody mapping for faster vaccine design

KTU experts reveal why cultural heritage is important for community unity

More misfolded proteins than previously known may contribute to Alzheimer’s and dementia

“Too much going on”: Autistic adults overwhelmed by non-verbal social cues

What’s driving America’s deep freezes in a warming world?

A key role of brain protein in learning and memory is deciphered by scientists

Heart attacks don’t follow a Hollywood script

Erin M. Schuman wins 2026 Nakasone Award for discovery on neural synapse function and change during formation of memories

Global ocean analysis could replace costly in-situ sound speed profiles in seafloor positioning, study finds

Power in numbers: Small group professional coaching reduces rates of physician burnout by nearly 30%

Carbon capture, utilization, and storage: A comprehensive review of CCUS-EOR

New high-temperature stable dispersed particle gel for enhanced profile control in CCUS applications

[Press-News.org] Large-scale identification and analysis of suppressive drug interactions